BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
3071 – 3080 of 3090
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Genetic bottlenecks and the hazardous game of population reduction in cell line based research.
(
- Contribution to journal › Article
-
Mark
Ubiquitin chain cleavage: CYLD at work.
(
- Contribution to journal › Article
-
Mark
Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns.
(
- Contribution to journal › Article
-
Mark
Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype.
(
- Contribution to journal › Article
-
Mark
Young age at diagnosis is a risk factor for negative late socio-economic effects after acute lymphoblastic leukemia in childhood.
(
- Contribution to journal › Article
-
Mark
Gene Expression Profiling-Based Identification of Molecular Subtypes in Stage IV Melanomas with Different Clinical Outcome.
(
- Contribution to journal › Article
-
Mark
Ornithine decarboxylase and extracellular polyamines regulate microvascular sprouting and actin cytoskeleton dynamics in endothelial cells.
(
- Contribution to journal › Article
-
Mark
Identification of uniquely expressed transcription factors in highly purified B-cell lymphoma samples.
(
- Contribution to journal › Article
-
Mark
Cystatin E/M suppresses legumain activity and invasion of human melanoma
(
- Contribution to journal › Article
-
Mark
SOX11 as a Cancer Biomarker - Expression and Regulatory Studies in B-cell Lymphomas and Ovarian Cancer
2010)(
- Thesis › Doctoral thesis (compilation)